Infectious Diseases News and Research

RSS

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

The study found protease inhibitors inhibited the growth of P. falciparum, the malaria parasite that causes most disease. These findings may also expose a previously unexplored vulnerability in the parasite that could lead to a new class of anti-malarial drug.

8 Nov 2004

Turf burns and body shaving responsible for the spread of a bacterial skin infection among football players

Turf burns and cosmetic body shaving were responsible for the spread of a bacterial skin infection among players on a college football team, according to an article in the November 15 issue of Clinical Infectious Diseases, now available online.

5 Nov 2004

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

The New England Journal of Medicine published today a study entitled "Mass Treatment with Single-Dose Azithromycin for Trachoma."

4 Nov 2004

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

VaxGen announced today that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense.

4 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

"Does Racial Concordance Between HIV-Positive Patients and Their Physicians Affect the Time to Receipt of Protease Inhibitors?" is published in the November issue of the Journal of General Internal Medicine.

4 Nov 2004

Benefits to human health associated with the use of antibiotics in chicken may outweigh the potential risks

The potential benefits to human health associated with the use of antibiotics in chicken may outweigh the potential risks, according to a risk-benefit analysis conducted by a team of researchers led by Randall S. Singer, D.V.M., Ph.D., of the University of Minnesota College of Veterinary Medicine.

4 Nov 2004

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).

4 Nov 2004

Gene regulated by need to process proteins linked to enlargement of protein processing factory

Part of a cellular mechanism that regulates the folding of new proteins into their proper shapes also includes a genetic response that enlarges the factory where both protein folding and packaging of proteins occurs.

2 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004

New vaccines to counter biological agents such as anthrax

Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.

1 Nov 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Insects implicated in the evolution of new human infectious diseases

Insects and other invertebrates are the arena for the evolution of new infectious diseases in humans, new research shows.

25 Oct 2004

New understanding of how poxviruses jump from species to species

A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species -- and will lead to further exploration of another potential candidate in the emerging field of “oncolytic viruses” to fight cancer.

25 Oct 2004

Microcrustaceans defeat dengue fever

Dengue fever causes 50 million infections annually in more than 90 countries; however this may soon become a thing of the past, as QIMR broadens its successful and totally environmentally-friendly mosquito-breeding control programs against dengue fever.

22 Oct 2004

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.

22 Oct 2004

Infectious Diseases News and Research

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

Turf burns and body shaving responsible for the spread of a bacterial skin infection among football players

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

Vaccine contributions to health highlighted at PAHO meeting

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

Benefits to human health associated with the use of antibiotics in chicken may outweigh the potential risks

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Gene regulated by need to process proteins linked to enlargement of protein processing factory

$73 million to tackle infectious diseases such as West Nile virus and influenza

New vaccines to counter biological agents such as anthrax

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

New molecular tool to pinpoint DNA mutations among thousands of cells

Infectious diseases physicians call for financial incentives for industry

Insects implicated in the evolution of new human infectious diseases

New understanding of how poxviruses jump from species to species

Microcrustaceans defeat dengue fever

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News